Determinants of survival in patients on extracorporeal membrane oxygenation therapy due to severe covid-19.

Ruslan Natanov, Elena R Kunkel,Olaf Wiesner,Axel Haverich,Bettina Wiegmann,Stefan Rümke,Christian Kühn

Perfusion（2022）

Cited 3|Views5

No score

Abstract

Pre-existing cardiovascular disease, higher age, history of nicotine abuse, and development of renal failure are associated with poor outcome. Early start of vv-ECMO therapy may lead to better survival in sCOVID-19 patients, although complications during ECMO therapy are associated with a worse prognosis.

Translated text

Key words

acute respiratory distress syndrome,coronavirus disease-19,determinants,extracorporeal membrane oxygenation,respiratory failure

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined